Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2672 (112th)

Preserving Access to Orphan Drugs Act of 2011

referredUnited States· United States Congress· EN

Introduced

27 July 2011

Last action

1 August 2011 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Gerlach, Jim [R-PA-6], Rep. Altmire, Jason [D-PA-4], Rep. Kinzinger, Adam [R-IL-16], Rep. Meehan, Patrick [R-PA-7], Rep. Paulsen, Erik [R-MN-3], Rep. Frank, Barney [D-MA-4], Rep. Schwartz, Allyson Y. [D-PA-13], Rep. Nunes, Devin [R-CA-22], Rep. Brady, Kevin [R-TX-8], Rep. Kelly, Mike [R-PA-16], Rep. Holden, Tim [D-PA-17], Rep. Burgess, Michael C. [R-TX-26], Rep. Thompson, Glenn [R-PA-15], Rep. Marchant, Kenny [R-TX-24], Rep. Jenkins, Lynn [R-KS-2], Rep. Guthrie, Brett [R-KY-2], Rep. Rangel, Charles B. [D-NY-15], Rep. McKinley, David B. [R-WV-1], Rep. Latham, Tom [R-IA-3], Rep. Broun, Paul C. [R-GA-10], Rep. Latta, Robert E. [R-OH-5], Rep. Paul, Ron [R-TX-14], Rep. Lee, Barbara [D-CA-12], Rep. Schrader, Kurt [D-OR-5], Rep. Kissell, Larry [D-NC-8], Rep. Carson, André [D-IN-7], Rep. Engel, Eliot L. [D-NY-16], Rep. Carnahan, Russ [D-MO-3], Rep. Kind, Ron [D-WI-3], Sen. Peters, Gary C. [D-MI], Rep. Owens, William L. [D-NY-23], Rep. Sanchez, Loretta [D-CA-46], Rep. Himes, James A. [D-CT-4], Sen. Heinrich, Martin [D-NM], Rep. Sires, Albio [D-NJ-13], Rep. Neal, Richard E. [D-MA-1], Rep. Dent, Charles W. [R-PA-15]

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Preserving Access to Orphan Drugs Act of 2011 - Amends the Patient Protection and Affordable Care Act (PPACA) to exclude any drug or biological product which is approved or licensed by the Food and Drug Administration (FDA) for marketing solely for one or more rare diseases or conditions from the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million. Makes this Act effective as if included in PPACA.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 27 July 2011

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 27 July 2011

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 27 July 2011

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 1 August 2011

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 27 July 2011

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 27 July 2011

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 27 July 2011

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.